Literature DB >> 9136959

Relapse of Philadelphia chromosome positive acute lymphoblastic leukaemia after marrow transplantation: sustained molecular remission after early and dose-escalating infusion of donor leucocytes.

F Keil1, P Kalhs, O A Haas, G Fritsch, E Reiter, C Mannhalter, K Lechner, G Leitner, H T Greinix.   

Abstract

We present a patient who underwent sibling allogeneic BMT because of refractory Ph+ve ALL and remained BCR-ABL-positive after marrow grafting. Haemopoietic precursor cells were predominantly BCR-ABL-negative and of donor origin. In T cells an exclusively donor genotype was demonstrated. Despite donor leucocyte infusion (DLI), 20 weeks after BMT BCR-ABL fusion mRNA increased in semiquantitative polymerase chain reaction and leukaemic infiltration of the patient's bone marrow was seen. After a second course of DLI the patient achieved sustained molecular remission but he developed severe graft-versus-host disease (GvHD) and died from bacterial sepsis 9 months after DLI.

Entities:  

Mesh:

Year:  1997        PMID: 9136959     DOI: 10.1046/j.1365-2141.1997.262674.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  5 in total

1.  Successful eradication of residual bcr-abl-positive clones by donor leukocyte transfusion in a patient with philadelphia chromosome-positive acute lymphoblastic leukemia after peripheral blood stem cell transplantation.

Authors:  T Tabayashi; K Masuda; K Yamada; M Takeuchi; K Matsue
Journal:  Int J Hematol       Date:  2001-10       Impact factor: 2.490

2.  Natural killer cell-enriched donor lymphocyte infusions from A 3-6/6 HLA matched family member following nonmyeloablative allogeneic stem cell transplantation.

Authors:  David A Rizzieri; Robert Storms; Dong-Feng Chen; Gwynn Long; Yiping Yang; Daniel A Nikcevich; Cristina Gasparetto; Mitchell Horwitz; John Chute; Keith Sullivan; Therese Hennig; Debashish Misra; Christine Apple; Megan Baker; Ashley Morris; Patrick G Green; Vic Hasselblad; Nelson J Chao
Journal:  Biol Blood Marrow Transplant       Date:  2010-02-24       Impact factor: 5.742

3.  Response and toxicity of donor lymphocyte infusions following T-cell depleted non-myeloablative allogeneic hematopoietic SCT from 3-6/6 HLA matched donors.

Authors:  D A Rizzieri; P Dev; G D Long; C Gasparetto; K M Sullivan; Ml Horwitz; J Chute; N J Chao
Journal:  Bone Marrow Transplant       Date:  2008-10-13       Impact factor: 5.483

Review 4.  Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors:  A K Fielding; G A Zakout
Journal:  Curr Hematol Malig Rep       Date:  2013-06       Impact factor: 3.952

5.  Rapid improvement of disseminated intravascular coagulation by donor leukocyte infusions in a patient with promyelocytic crisis of chronic myelogenous leukemia after reduced-intensity stem cell transplantation from an HLA 2-antigen-mismatched mother.

Authors:  Kosei Matsue; Konagi Yamada; Masami Takeuchi; Takayuki Tabayashi
Journal:  Int J Hematol       Date:  2003-05       Impact factor: 2.490

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.